Analystreport

Orchard Therapeutics PLC - (NASDAQ: ORTX) had its "buy" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $26.00 price target on the stock.

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report